Ustekinumab-aekn
NDC 51759-413, ustekinumab-aekn, injection, solution, from Teva Pharmaceuticals USA, Inc..
- Product NDC
- 51759-413
- Status
- Listed
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761343
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51759-413 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- USTEKINUMAB-AEKN45 mg/.5mL
Pharmacologic classes
Interleukin-12 Antagonist [EPC]; Interleukin-12 Antagonists [MoA]; Interleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51759-413-32 | 51759041332 | 1 TRAY in 1 CARTON (51759-413-32) / 1 SYRINGE, GLASS in 1 TRAY / .5 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/052a3fb2-21c3-4c4e-a01e-afdd1accd1cdMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=51759-413
Use it
Look up 51759-413 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51759-413 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51759-413. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.